AC005841.1 | Uncharacterized protein ENSP00000372125 | | | | | | Tissue enhanced |
ANKDD1B | Ankyrin repeat and death domain containing 1B | | | | | | Tissue enhanced |
ANKRD20A3 | Ankyrin repeat domain 20 family, member A3 | | | | | | Tissue enhanced |
ANKRD33B | Ankyrin repeat domain 33B | | | | | | Mixed |
ANKRD61 | Ankyrin repeat domain 61 | | | | | | Group enriched |
ANKRD63 | Ankyrin repeat domain 63 | | | | | | Not detected |
ARL14EPL | ADP-ribosylation factor-like 14 effector protein-like | | | | | | Not detected |
C10orf115 | Chromosome 10 open reading frame 115 | | | | | | Tissue enhanced |
C11orf89 | Chromosome 11 open reading frame 89 | | | | | | Tissue enhanced |
C11orf94 | Chromosome 11 open reading frame 94 | Predicted secreted proteins
| | | | | Tissue enriched |
C12orf79 | Chromosome 12 open reading frame 79 | | | | | | Tissue enriched |
C17orf112 | Chromosome 17 open reading frame 112 | | | | | | Tissue enriched |
C17orf98 | Chromosome 17 open reading frame 98 | | | | | | Tissue enriched |
C18orf42 | Chromosome 18 open reading frame 42 | | | | | | Tissue enriched |
C19orf71 | Chromosome 19 open reading frame 71 | | | | | | Tissue enhanced |
C19orf81 | Chromosome 19 open reading frame 81 | | | | | | Tissue enhanced |
C19orf82 | Chromosome 19 open reading frame 82 | | | | | | Expressed in all |
C19orf84 | Chromosome 19 open reading frame 84 | | | | | | Tissue enriched |
C1orf134 | Chromosome 1 open reading frame 134 | Predicted secreted proteins
| | | | | Mixed |
C1orf137 | Chromosome 1 open reading frame 137 | | | | | | Not detected |
C1orf233 | Chromosome 1 open reading frame 233 | Predicted membrane proteins
| | | | | Mixed |
C20orf187 | Chromosome 20 open reading frame 187 | | | | | | Tissue enriched |
C20orf78 | Chromosome 20 open reading frame 78 | | | | | | Tissue enriched |
C3orf79 | Chromosome 3 open reading frame 79 | | | | | | Not detected |
C3orf83 | Chromosome 3 open reading frame 83 | | | | | | Mixed |
C4orf51 | Chromosome 4 open reading frame 51 | | | | | | Tissue enriched |
C5orf55 | Chromosome 5 open reading frame 55 | | | | | | Mixed |
C5orf58 | Chromosome 5 open reading frame 58 | | | | | | Tissue enriched |
C6orf100 | Chromosome 6 open reading frame 100 | | | | | | Not detected |
C6orf226 | Chromosome 6 open reading frame 226 | | | | | | Expressed in all |
C6orf229 | Chromosome 6 open reading frame 229 | | | | | | Tissue enriched |
C6orf99 | Chromosome 6 open reading frame 99 | | | | | | Tissue enriched |
C7orf66 | Chromosome 7 open reading frame 66 | | | | | | Tissue enriched |
C7orf72 | Chromosome 7 open reading frame 72 | | | | | | Tissue enriched |
C7orf73 | Chromosome 7 open reading frame 73 | Predicted secreted proteins
| | | | | Expressed in all |
C8orf12 | Chromosome 8 open reading frame 12 | | | | | | Tissue enhanced |
C8orf87 | Chromosome 8 open reading frame 87 | | | | | | Not detected |
C9orf53 | Chromosome 9 open reading frame 53 | | | | | | Not detected |
C9orf92 | Chromosome 9 open reading frame 92 | Predicted membrane proteins
| | | | | Tissue enhanced |
CCDC166 | Coiled-coil domain containing 166 | | | | | | Not detected |
CCDC179 | Coiled-coil domain containing 179 | | | | | | Tissue enriched |
CCER2 | Coiled-coil glutamate-rich protein 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
CFC1B | Cripto, FRL-1, cryptic family 1B | Predicted secreted proteins
| | | | | Group enriched |
CT47B1 | Cancer/testis antigen family 47, member B1 | | | | | | Tissue enriched |
CXorf65 | Chromosome X open reading frame 65 | | | | | | Tissue enhanced |
DCDC2C | Doublecortin domain containing 2C | | | | | | Tissue enriched |
EFCAB9 | EF-hand calcium binding domain 9 | | | | | | Tissue enriched |
IQCF6 | IQ motif containing F6 | Predicted secreted proteins
| | | | | Tissue enriched |
LIMS3L | LIM and senescent cell antigen-like domains 3-like | | | | | | Tissue enhanced |
LRRC10B | Leucine rich repeat containing 10B | | | | | | Tissue enriched |